Microbiotix, Inc. is a clinical stage biopharmaceutical company forging strong partnerships
to foster innovation in infectious disease therapeutics. These are some of the exemplary
partners that we receive funding and expertise from:

• CARB-X, a public-private partnership funded by the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services and the Wellcome Trust;
• The AMR Centre is a key part of the UK’s response to the global threat from antimicrobial resistance. Based at Alderley Park, The AMR Centre is a joint private-public initiative to support/accelerate the development of new antibiotics and diagnostics through a fully integrated development capability, offering translational R&D from pre-clinical hits through to clinical proof of concept;
• U.S. National Institute of Allergy and Infectious Diseases (NIAID);
• U.S. Department of Defense (DoD).

For information about how we can become partners, contact us.